3EAH | Oxidoreductase | date | Aug 25, 2008 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Structure Of Inhibited Human Enos Oxygenase Domain | ||||||||||||||
authors | E.D.Garcin, A.S.Arvai, R.J.Rosenfeld, M.D.Kroeger, B.R.Crane, G.A G.Andrews, P.J.Hamley, P.R.Mallinder, D.J.Nicholls, S.A.St-Gall A.C.Tinker, N.P.Gensmantel, A.Mete, D.R.Cheshire, S.Connolly, D. A.Aberg, A.V.Wallace, J.A.Tainer, E.D.Getzoff | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Nitric Oxide Synthase, Endothelial Chain: A, B Synonym: Nos Type III, Endothelial Nos, Cnos, Enos, Nosiii, Constitutive Nos; Ec: 1.14.13.39 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Nos3 Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Bl21(De3) Expression_system_vector_type: Plasmid Expression_system_plasmid: Pcwori | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.44 Å | ||||||||||||
ligand | 327, CL, HEC, MPD, ZN BindingDB | enzyme | Oxidoreductase E.C.1.14.13.39 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase., Garcin ED, Arvai AS, Rosenfeld RJ, Kroeger MD, Crane BR, Andersson G, Andrews G, Hamley PJ, Mallinder PR, Nicholls DJ, St-Gallay SA, Tinker AC, Gensmantel NP, Mete A, Cheshire DR, Connolly S, Stuehr DJ, Aberg A, Wallace AV, Tainer JA, Getzoff ED, Nat Chem Biol. 2008 Nov;4(11):700-7. Epub 2008 Oct 12. PMID:18849972 |
Data retrieval |
View 3EAH in 3D |
Visual 3D analysis of 3EAH |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3EAH |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |